Colonial Trust Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.52K Hold
20
– – ﹤0.01% 676
2026
Q2
$4.32K Hold
20
– – ﹤0.01% 676
2026
Q1
$3.67K Hold
20
– – ﹤0.01% 627
2025
Q4
$3.52K Hold
20
– – ﹤0.01% 612
2025
Q3
$2.8K Hold
20
– – ﹤0.01% 609
2025
Q2
$2.51K Buy
+20
New +$2.49K ﹤0.01% 630
2024
Q1
– Sell
-4
Closed -$1.04K – 1029
2023
Q4
$1.04K Hold
4
– – ﹤0.01% 768
2023
Q3
$1.03K Hold
4
– – ﹤0.01% 772
2023
Q2
$1.14K Hold
4
– – ﹤0.01% 787
2023
Q1
$1.11K Sell
4
-1
-20% -$277 ﹤0.01% 785
2022
Q4
$1.38K Buy
+5
New +$1.41K ﹤0.01% 767

Other funds holding BIIB

Colonial Trust Advisors's BIIB Position: Q3 2026 in Review

Colonial Trust Advisors held its Biogen (BIIB) position steady in Q3 2026 at 20 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Colonial Trust Advisors first reported a position in BIIB in Q4 2022 and has held it in 11 quarters since. 1,054 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Colonial Trust Advisors held 20 shares of Biogen worth $4.52K as of Q3 2026.
  • Colonial Trust Advisors left its Biogen share count unchanged in Q3 2026.
  • Biogen made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q3 2026, its #676 holding.
  • Colonial Trust Advisors first reported a position in Biogen in Q4 2022 and has held it in 11 quarters since.
  • 1,054 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Colonial Trust Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.